Sfoglia per Autore
Angiogenesis and Fibrogenesis in Chronic Liver Diseases
2015-01-01 Bocca, Claudia; Novo, Erica; Miglietta, Antonella; Parola, Maurizio
Hepatic myofibroblasts and fibrogenic progression of chronic liver diseases
2015-01-01 Novo, Erica; Cannito, Stefania; Morello, Elisabetta; Paternostro, Claudia; Bocca, Claudia; Miglietta, Antonella; Parola, Maurizio
Microparticles released as a consequence of lipid-induced toxicity promote NLRP3 inflammasome activation in HepG2 cells.
2014-01-01 Paternostro C; Benetti E; Cannito S; Novo E; Chiazza F; Rogazzo M; Bocca C; Fantozzi R; Povero D; Feldstein A; Collino M; Parola M.
Microparticles released as a consequence of lipid-induced toxicity promote NLRP3 inflammasome activation in HepG2 cells
2014-01-01 Paternostro C; Benetti E; Cannito S; Novo E; Chiazza F; Rogazzo M; Bocca C; Fantozzi R; Povero D; Feldstein A; Collino M; Parola M.
Microparticles released by fat-laden cells activate in a paracrine way NLRP3 inflammasome in both HepG2 cells and macrophages.
2014-01-01 Novo E; Paternostro C; Benetti E; Cannito S; Bocca C; Morello E; Chiazza F; Fantozzi R; Povero D; Feldstein A; Collino M; Parola M.
SERPIN-B3 can contribute to fibrogenic progression of chronic liver diseases towards cirrhosis and HCC development
2014-01-01 Cannito S; Turato C; Morello E; Biasiolo A; Paternostro C; Novo E; Bocca C; Villano G; Quarta S; Rovida E; David E; Colombatto S; Pontisso P; Parola M
Microparticles released by fat-laden cells activate in a paracrine way NLRP3 inflammasome in both HepG2 cells and macrophages.
2014-01-01 Morello E; Paternostro C; Benetti E; Cannito S; Novo E; Chiazza F; Rogazzo M; Bocca C; Fantozzi R; Povero D; Feldstein A; Collino M; Parola M
Hypoxia, hypoxia inducible factors and fibrogenesis in chronic liver diseases
2014-01-01 Cannito S; Paternostro C; Busletta C; Bocca C; Colombatto S; Miglietta A; Novo E; Parola M.
EXPRESSION OF COX-2 IN HUMAN BREAST CANCER CELLS AS A CRITICAL DETERMINANT OF EPITHELIAL-MESENCHYMAL TRANSITION AND INVASIVENESS
2014-01-01 C. BOCCA; M. IEVOLELLA; R. AUTELLI; M. MOTTA; L. MOSSO; B. TORCHIO; F. BOZZO; S. CANNITO; C. PATERNOSTRO; S. COLOMBATTO; M. PAROLA; A. MIGLIETTA
Cellular And Molecular Mechanisms In Liver Fibrogenesis.
2014-01-01 Novo E; Cannito S; Paternostro C; Bocca C; Miglietta A; Parola M.
COX2 inhibitor NS398 reduces HT-29 cell invasiveness by modulating signaling pathways mediated by EGFR and HIF1-α
2014-01-01 Bocca C; Bozzo F; Miglietta A
EXPRESSION OF COX-2 IN HUMAN BREAST CANCER CELLS AS A CRITICAL DETERMINANT OF EPITHELIAL-MESENCHYMAL TRANSITION AND INVASIVENESS
2013-01-01 Ievolella M; Bocca C; Autelli R; Motta M; Torchio B; Mosso L; Cannito S; Paternostro C; Colombatto S; Parola M; Miglietta A
Celecoxib inactivates epithelial-mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cells
2012-01-01 Bocca C; Bozzo F; Cannito S; Parola M; Miglietta A
A NOVEL NITRO-OXY SUBSTITUTED ANALOGUE OF ROFECOXIB REDUCES HUMAN COLON CANCER CELL GROWTH
2012-01-01 Claudia BOCCA; Francesca BOZZO; Monica IEVOLELLA; Antonella MIGLIETTA
RELATIONSHIP OF GENETIC VARIATIONS OF THE GENE CODING FOR THE HUMAN EQUILIBRATIVE NUCLEOSIDE TRANSPORTER-1 (HENT1) WITH PROTEIN EXPRESSION AND RESPONSE TO TREATMENT IN CHRONIC HEPATITIS C
2011-01-01 Tarabra E; Framarin L; Actis GC; Bocca C; Baiocchi L; Borghesio E; Tappero G; Carenzi S; Berrutti M; Ciancio A; Tabone M; Picciotto A; Grasso A; Artioli S; Rizzi R; Vecchi E; Strona S; Fazio V; Pistone C; Cassano V; Predebon S; Tibaudi D; Rosina F
Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines.
2011-01-01 C. Bocca; F. Bozzo; A. Bassignana; A. Miglietta
CLA reduces breast cancer cell growth and invasion through ERα and PI3K/Akt pathways
2010-01-01 Bocca C; Bozzo F; Cannito S; Colombatto S; Miglietta A.
Antiproliferative effect of a novel nitro-oxy derivative of celecoxib in human colon cancer cells: role of COX-2 and nitric oxide.
2010-01-01 Bocca C; Bozzo F; Bassignana A; Miglietta A.
COX-2 expression in human breast carcinomas: correlation with clinicopathological features and prognostic molecular markers.
2010-01-01 Miglietta A; Toselli M; Ravarino N; Vencia W; Chiecchio A; Bozzo F; Motta M; Torchio B; Bocca C.
Anti-cancer effect of CLA: A matter of multiple interactions between signalling pathways involving Src, IGF and PPAR-γ pathway?
2010-01-01 Bocca Claudia
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile